TA
BLU

TLS Advisors’s BELLUS Health Inc. BLU Stock Holding History

TLS Advisors’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-125,731
Closed -$905K – 18
2023
Q1 		$905K Hold
125,731
– – 4.65% 8
2022
Q4 		$1.03M Buy
+125,731
New +$1.17M 5.1% 8

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.32B AUM 51.82% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

TLS Advisors's BLU Position: Q2 2023 in Review

TLS Advisors sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 125,731 shares — an estimated $905K sold.

TLS Advisors first reported a position in BLU in Q4 2022 and held it in 2 quarters. The position peaked at $1.03M in Q4 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • TLS Advisors reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • TLS Advisors sold 125,731 BELLUS Health Inc. shares in Q2 2023, an estimated $905K.
  • TLS Advisors first reported a position in BELLUS Health Inc. in Q4 2022 and held it in 2 quarters.
  • TLS Advisors's BELLUS Health Inc. position peaked at $1.03M in Q4 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on TLS Advisors's 13F filing for Q2 2023, filed 16 Nov 2023.